The State Street SPDR S&P Pharmaceuticals ETF aims to deliver investment results that closely correspond to the total return of the S&P Pharmaceuticals Select Industry Index, prior to accounting for fees and expenses. It offers investors focused access to the pharmaceuticals segment, specifically the Pharmaceuticals sub-industry as classified by the S&P Total Market Index. By tracking a modified equal-weighted index, the fund ensures a balanced industry exposure across companies of various sizes, including large, mid, and small-cap stocks, thereby mitigating concentration risk. This design provides a more granular approach, empowering investors to adopt strategic or tactical positions within the pharmaceutical sector with greater specificity than traditional, broader sector-based investment vehicles.